Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Triple negative breast cancer
ADR ID BADD_A11087
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.10      Breast neoplasms malignant and unspecified (incl nipple)
16.10.01      Breast and nipple neoplasms malignant
16.10.01.020      Triple negative breast cancer
21      Reproductive system and breast disorders
21.05      Breast disorders
21.05.01      Benign and malignant breast neoplasms
21.05.01.032      Triple negative breast cancer
Description Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN. [MeSH]
MedDRA Code 10075566
MeSH ID D064726
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Triple negative breast cancer | Triple negative breast cancer metastatic | Triple Negative Breast Neoplasms | ER-Negative PR-Negative HER2-Negative Breast Neoplasms | ER Negative PR Negative HER2 Negative Breast Neoplasms | Triple-Negative Breast Cancer | Breast Cancer, Triple-Negative | Breast Cancers, Triple-Negative | Triple-Negative Breast Cancers | Triple-Negative Breast Neoplasm | Breast Neoplasm, Triple-Negative | Breast Neoplasms, Triple-Negative | Triple Negative Breast Neoplasm | Triple-Negative Breast Neoplasms | ER-Negative PR-Negative HER2-Negative Breast Cancer | ER Negative PR Negative HER2 Negative Breast Cancer | Triple Negative Breast Cancer
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00349Capecitabine0.000112%
BADD_D00680Dimethyl fumarate0.000400%
BADD_D01281Levonorgestrel0.000709%
The 1th Page    1    Total 1 Pages